The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Modulation of Irinotecan Pharmacokinetics/Pharmacodynamics by Combined Treatment with Neomycin.
 
Yu Sunakawa
Honoraria - Chugai Pharma; Kyowa Hakko Kirin; Lilly Japan; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Chugai Pharma (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Yakult Honsha (Inst)
 
Hironaga Satake
No Relationships to Disclose
 
Joshua L. Usher
No Relationships to Disclose
 
Yolanda S Jaimes
No Relationships to Disclose
 
Yuji Miyamoto
No Relationships to Disclose
 
Masato Nakamura
Honoraria - Chugai Pharma; Lilly; Merck; Taiho Pharmaceutical; Takeda; Yakult Honsha
Consulting or Advisory Role - Bayer; Merck
 
Hiroshi Nakayama
No Relationships to Disclose
 
Nobuhiro Sugano
No Relationships to Disclose
 
Akinori Takagane
No Relationships to Disclose
 
Masahiro Gotoh
Honoraria - Chugai Pharma; Lilly Japan; Merck Serono; Mochida Pharmaceutical Co. Ltd.; Nippon Kayaku; Ono Pharmaceutical; Taiho Pharmaceutical; Yakult Honsha
Research Funding - Chugai Pharma; Kyowa Hakko Kirin; Mochida Pharmaceutical Co. Ltd.; Nippon Kayaku; Taiho Pharmaceutical
 
Takanori Watanabe
No Relationships to Disclose
 
Kiyoshi Ishigure
No Relationships to Disclose
 
Chihiro Tanaka
No Relationships to Disclose
 
Masahiro Takeuchi
Consulting or Advisory Role - Abbvie; AstraZeneca Japan; Hisamitsu Pharmaceutical; Mitsubishi Tanabe Pharma; Shionogi; Taiho Pharmaceutical
 
Masashi Fujii
Travel, Accommodations, Expenses - Japan Clinical Cancer Research Organization
 
KATHLEEN DANENBERG
Leadership - Liquid Genomics, Inc.
Stock and Other Ownership Interests - Liquid Genomics, Inc.
Patents, Royalties, Other Intellectual Property - RNA extraction from human blood (Inst)
Travel, Accommodations, Expenses - Liquid Genomics, Inc.
 
Heinz-Josef Lenz
Honoraria - Bayer; Boehringer Ingelheim; Merck Serono; Roche
Consulting or Advisory Role - Bayer; Merck Serono; Pfizer; Roche
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche
 
Takashi Sekikawa
No Relationships to Disclose
 
Wataru Ichikawa
Honoraria - Chugai Pharma; Daiichi Sankyo; Merck Serono; Nippon Kayaku; Sawai Pharmaceutical Co; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Daiichi Sankyo; Merck Serono; Ono Pharmaceutical; Zeria Pharmaceutical
Research Funding - Eisai; Taiho Pharmaceutical; Takeda
Travel, Accommodations, Expenses - Daiichi Sankyo